Peptide Compass · Research

TB-500: research, prices and suppliers

A synthetic fragment of the body's own protein thymosin beta-4, studied in preclinical research on cell migration and tissue regeneration.

Sources and dates are stated with individual entries. This new presentation is not a complete re-investigation of all data.

TB-500 is the synthetically produced, seven-amino-acid core sequence of the body's own protein thymosin beta-4. Most available data, including clinical studies, relate to the full 43-amino-acid thymosin beta-4, not to the isolated TB-500 fragment itself. Areas of study include cell migration, angiogenesis, and a possible role in hair follicle activation.

Facts

  • Molecular weight: 4963 g/mol
  • Amino acids: 43
  • Purity specification: ≥ 99 % (HPLC, commercial standard)

Evidence

  • A study in rats and mice described that the active sequence of thymosin beta-4, which also forms TB-500, influenced stem cell migration within the hair follicle. Philp et al. 2004, FASEB Journal, PMID 14657002
  • A randomized, placebo-controlled clinical trial in patients with severe dry eye tested an eye-drop formulation of the full thymosin beta-4 protein and described improved signs and symptoms compared with placebo. The trial involved the full protein, not the TB-500 fragment itself. Sosne et al. 2015, Cornea, PMID 25826322

Frequently asked questions

Is TB-500 the same as thymosin beta-4?


No. TB-500 is a synthetic seven-amino-acid fragment of the full 43-amino-acid thymosin beta-4 sequence. Most clinical data relate to the full protein, not the fragment.

Are there clinical studies on TB-500 itself?


No independent controlled human studies on the isolated TB-500 fragment are available. Available clinical data come from the full thymosin beta-4 protein.

Is TB-500 relevant to anti-doping rules?


Thymosin beta-4 and related fragments are on the World Anti-Doping Agency prohibited list.

Documented prices

Prices are recorded snapshots. Each entry states its date, currency and pack variant. Shipping, tax treatment, discount conditions and availability must be rechecked in the shop. A low price is not evidence of quality.

List prices excluding shipping and discounts. Currency and product variants must be compared separately. Availability and delivered batch have not been verified.

VendorPackList pricePrice/mgRecordedSource
Driada2 mg29 EUR14.5 EUR/mg2026-09-15Product page · Ad
Europa-Peptide5 mg39.9 EUR7.98 EUR/mg2026-09-15Product page · Ad
Peak Peptide5 mg44.9 EUR8.98 EUR/mg2026-09-15Product page · Ad
Peptide Labz5 mg50 EUR10.0 EUR/mg2026-09-15Product page · Ad
PPX.at5 mg50 EUR10.0 EUR/mg2026-09-15Product page · Ad
Peptidwerk10 mg34.95 EUR3.5 EUR/mg2026-09-15Product page · Ad
Bio BoostX10 mg45.95 EUR4.6 EUR/mg2026-09-15Product page · Ad
Smart Peptides10 mg49.9 EUR4.99 EUR/mg2026-09-15Product page · Ad
Beyond Peptides10 mg64.69 EUR6.47 EUR/mg2026-09-15Product page · Ad
Peptide Shop Deutschland10 mg67.99 EUR6.8 EUR/mgnot establishedProduct page · Ad
Particle Peptides10 mg79.99 EUR8.0 EUR/mg2026-09-15Product page · Ad
DN Lab Research15 mg185 EUR12.33 EUR/mg2026-09-15Product page · Ad
BioCollex10 mg50 USD5.0 USD/mg2026-09-15Product page · Ad
Chameleon Peptides10 mg72.9 USD7.29 USD/mg2026-09-15Product page · Ad
Protide Health10 mg85 USD8.5 USD/mg2026-09-15Product page · Ad
Hydro Research Peptides10 mg90 USD9.0 USD/mg2026-09-15Source
Licensed Peptides10 mg99.99 USD10.0 USD/mg2026-09-15Product page · Ad
American Peptides10 mg100 USD10.0 USD/mg2026-09-15Product page · Ad

Questions about interpretation

What does the search “TB-500 protocol” mean?

“Protocol” is often used to mean a regimen. This page explains research and documented listings. It contains no doses, cycles or instructions for human use. An online regimen is not scientifically validated simply because it is widely shared.

Sources and data basis

These references come from the existing dataset. A link alone verifies neither a study claim nor supplier quality. Uncertainty remains explicit where records are undated or incomplete.

Where to go next

Created with AI assistance. This new edition has not yet received independent editorial review.